PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
2 hedge funds and large institutions have $2.52M invested in PureTech Health in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
232% more capital invested
Capital invested by funds: $759K → $2.52M (+$1.76M)
0.22% more ownership
Funds ownership: 0.01% → 0.23% (+0.22%)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$14.5M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$8.01K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $2.51M | +$14.5M | +630,000 | +2,100% |
|
|
2
UBS Group
Zurich,
Switzerland
| $7K | +$8.01K | +349 | +1,745% |
|
PRTC Hedge Fund Activity: Q2 2022 in Review
2 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q2 2022, worth a combined $2.52M — up 232% from $759K a quarter earlier.
Fund positioning in PRTC was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $14.5M.
- 2 institutional investors held PureTech Health (PRTC) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $2.52M of PureTech Health stock for Q2 2022, up 232% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q2 2022 and 0 closed out.
- The largest PureTech Health buyer in Q2 2022 was AWM Investment Company, an estimated $14.5M added.
Based on aggregated 13F filings for Q2 2022.